A naukri.com initiative
Medium
1M
411
Image Credit: Medium
Phoenix Lifesciences: Redefining Aging Through mRNA Innovation
- Phoenix Lifesciences is redefining aging through mRNA innovation with a focus on healthspan extension.
- Their approach targets fundamental hallmarks of aging using mRNA therapies delivered via advanced lipid nanoparticle technology.
- The platform can simultaneously deliver multiple mRNA constructs addressing different aging pathways for a synergistic effect.
- Interventions include telomere extension, mitochondrial DNA stabilization, DNA repair enhancement, and epigenetic pattern reset.
- Results from studies show improvements in cellular rejuvenation, energy production, DNA damage reduction, and gene expression patterns.
- The global longevity therapeutics market is projected to grow significantly, reflecting both scientific progress and market demand.
- The average American faces significant healthcare costs due to age-related conditions, which could be reduced by delaying disease onset with these therapies.
- Phoenix Lifesciences' development pathway aims to balance scientific rigor with market opportunity for transformative aging interventions.
- Investing in Phoenix Lifesciences means contributing to a revolution where aging becomes an opportunity for longer, healthier, and financially secure lives.
Read Full Article
24 Likes
For uninterrupted reading, download the app